Publication:
Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis.

dc.contributor.authorCallejas Rubio, José Luis
dc.contributor.authorRíos Fernández, Raquel
dc.contributor.authorDe la Hera Fernández, Javier
dc.date.accessioned2023-05-03T15:07:52Z
dc.date.available2023-05-03T15:07:52Z
dc.date.issued2021-05-27
dc.identifier.doi10.1016/j.medcli.2021.05.003
dc.identifier.essn1578-8989
dc.identifier.pmcPMC8157119
dc.identifier.pmid34119341
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157119/pdf
dc.identifier.unpaywallURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157119
dc.identifier.urihttp://hdl.handle.net/10668/22359
dc.issue.number2
dc.journal.titleMedicina clinica
dc.journal.titleabbreviationMed Clin (Barc)
dc.language.isoen
dc.language.isoes
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario San Cecilio
dc.page.number91-92
dc.pubmedtypeCase Reports
dc.rights.accessRightsopen access
dc.subject.meshAntibodies, Viral
dc.subject.meshCOVID-19
dc.subject.meshCOVID-19 Vaccines
dc.subject.meshGiant Cell Arteritis
dc.subject.meshHumans
dc.subject.meshSARS-CoV-2
dc.titleEfficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis.
dc.title.alternativeEficacia y seguridad de la vacuna frente a SARS-CoV-2 en pacientes con arteritis de células gigantes.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number158
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8157119.pdf
Size:
253.22 KB
Format:
Adobe Portable Document Format